Matches in Wikidata for { <http://www.wikidata.org/entity/Q92090017> ?p ?o ?g. }
- Q92090017 description "article scientifique publié en 2019" @default.
- Q92090017 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92090017 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92090017 description "scientific article published on 16 May 2019" @default.
- Q92090017 description "wetenschappelijk artikel" @default.
- Q92090017 description "наукова стаття, опублікована 16 травня 2019" @default.
- Q92090017 description "գիտական հոդված հրատարակված 2019 թվականի մայիսի 16-ին" @default.
- Q92090017 name "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 name "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 type Item @default.
- Q92090017 label "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 label "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 prefLabel "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 prefLabel "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 P1433 Q92090017-396EC19E-EF4C-478C-910C-C1E337D2BAD7 @default.
- Q92090017 P1476 Q92090017-6AEEF6B4-C35F-4156-BB73-9DA15FA702F7 @default.
- Q92090017 P2093 Q92090017-0AB749CF-81D2-455A-A956-DBCC5DCE85AA @default.
- Q92090017 P2093 Q92090017-336A6B69-5DAC-4116-A993-E3421EB7A407 @default.
- Q92090017 P2093 Q92090017-4FCE432C-870C-474E-B134-923247DCBEB9 @default.
- Q92090017 P2093 Q92090017-66971C17-5895-4600-AC92-E52E4607847E @default.
- Q92090017 P2093 Q92090017-69BE6545-2869-4EF8-BDB9-5D3C8751694D @default.
- Q92090017 P2093 Q92090017-7D239D71-0AA1-4DF8-AD91-D07D8F4A3072 @default.
- Q92090017 P2093 Q92090017-909AED4B-191B-4887-85E9-1DFB34FC2DB5 @default.
- Q92090017 P2093 Q92090017-94D7DE1F-32B4-4201-8CD1-D8B368D553C3 @default.
- Q92090017 P2093 Q92090017-9C1314C5-6ABE-4C51-A047-A7589A6B2F70 @default.
- Q92090017 P2093 Q92090017-9E963810-E2D4-4225-BD7C-D4D50AA81E3B @default.
- Q92090017 P2093 Q92090017-A63F9329-5C95-47D1-A2F5-122AEE066790 @default.
- Q92090017 P2093 Q92090017-AF4C7C14-13F7-4C75-A9B3-0103F27B697D @default.
- Q92090017 P2093 Q92090017-E1263744-5386-4FC8-9E95-D6F12436C628 @default.
- Q92090017 P2093 Q92090017-E3FC8B59-3F1E-4FA6-AB95-C13571C9409C @default.
- Q92090017 P2093 Q92090017-E88784EB-4F1A-43FD-838E-AA77E66F95A4 @default.
- Q92090017 P2093 Q92090017-EBF6CC9B-7D26-439D-8C30-97FC47622D65 @default.
- Q92090017 P2093 Q92090017-F7FB9C63-1796-4338-AF4F-93C81CAB8D1B @default.
- Q92090017 P2860 Q92090017-0EF7B753-F7A4-4720-A55C-7FBB0907971F @default.
- Q92090017 P2860 Q92090017-139312A9-1DD5-464B-A087-A29BA0328F17 @default.
- Q92090017 P2860 Q92090017-14846607-F9AD-498A-8E37-1F3775820AEE @default.
- Q92090017 P2860 Q92090017-183EB96A-CA87-4445-A4B8-4BAF69829188 @default.
- Q92090017 P2860 Q92090017-1A9567B5-7668-47F4-8526-54A5B294DF9D @default.
- Q92090017 P2860 Q92090017-27C3613A-03D3-4EA4-B512-1CD508C79B2D @default.
- Q92090017 P2860 Q92090017-2FA38760-5143-4CE8-9DED-F172285E7002 @default.
- Q92090017 P2860 Q92090017-36BF0B30-FDE1-49DE-AA7F-131BD31DDDC1 @default.
- Q92090017 P2860 Q92090017-4761A051-C093-4EC0-98D4-84ECD6F2242B @default.
- Q92090017 P2860 Q92090017-65A6CBB1-C21B-4716-8BA3-66BC176C3624 @default.
- Q92090017 P2860 Q92090017-6971A2F3-F66A-47B6-979F-6036E368B81B @default.
- Q92090017 P2860 Q92090017-6E68E41F-747B-44E3-A7D8-36211172DC1E @default.
- Q92090017 P2860 Q92090017-71A19F91-23B8-4310-A904-FE1A91AAE142 @default.
- Q92090017 P2860 Q92090017-79788471-548E-4F46-BB7D-70B8CB55AA26 @default.
- Q92090017 P2860 Q92090017-81A44DFC-7903-4851-9FF2-E69727474B01 @default.
- Q92090017 P2860 Q92090017-9459190E-3612-4350-944D-077FE8B77FC9 @default.
- Q92090017 P2860 Q92090017-AF0AAE1F-E283-4211-B180-7614F728E345 @default.
- Q92090017 P2860 Q92090017-B493B6A2-DF53-40DB-96AB-3E669E180F33 @default.
- Q92090017 P2860 Q92090017-B4DCC463-D390-4591-BEE8-489FE5637703 @default.
- Q92090017 P2860 Q92090017-C27BF857-4EC6-4FB3-96BC-4430292907CB @default.
- Q92090017 P2860 Q92090017-DB49AFEE-24A8-4FD0-BBE8-06E2291B9286 @default.
- Q92090017 P2860 Q92090017-F51580C4-B4B9-4476-B540-3300448B5145 @default.
- Q92090017 P2860 Q92090017-F7A24A54-A913-42E4-943D-E33F03C89F03 @default.
- Q92090017 P2860 Q92090017-FF798E3D-5701-44A2-A22D-F0984E5CAF36 @default.
- Q92090017 P304 Q92090017-155CFD27-AEA7-4C0A-9781-355CCE40654D @default.
- Q92090017 P31 Q92090017-10F541BC-459C-44E5-AF9E-83B45F2E6586 @default.
- Q92090017 P356 Q92090017-1695930D-9D6B-4F60-8A6E-46637616581D @default.
- Q92090017 P433 Q92090017-27C9F48A-88C3-43A8-9731-538B1887AE7E @default.
- Q92090017 P478 Q92090017-80DEB0F6-8844-4C69-AEF8-AAA6B1531D3A @default.
- Q92090017 P50 Q92090017-289B4713-BFD1-45FB-AF46-A3350E3250D2 @default.
- Q92090017 P50 Q92090017-60A9E44C-3731-4F0E-BFA4-47198A32D9EF @default.
- Q92090017 P577 Q92090017-8A4DDD94-5361-4348-AA21-471124E4F043 @default.
- Q92090017 P698 Q92090017-E76F8A33-D570-4822-B91F-1AD793A315D7 @default.
- Q92090017 P921 Q92090017-03F7CFC6-52B1-44DA-A890-4FD70AC10AB4 @default.
- Q92090017 P921 Q92090017-3FC1E894-2524-4AEF-B631-15906ABDBF31 @default.
- Q92090017 P921 Q92090017-544E69D7-59A5-48CC-8BEA-65F0C696CD38 @default.
- Q92090017 P921 Q92090017-BDDE869B-DA63-4846-89CC-D2B70A82A27F @default.
- Q92090017 P932 Q92090017-B85A0DE7-F52F-441F-B3A5-3D08F3E3C8DA @default.
- Q92090017 P356 HAEMATOL.2018.205930 @default.
- Q92090017 P698 31097627 @default.
- Q92090017 P1433 Q5638209 @default.
- Q92090017 P1476 "Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia" @default.
- Q92090017 P2093 "Ann Janssens" @default.
- Q92090017 P2093 "Anna Frömming" @default.
- Q92090017 P2093 "Diana Beyer" @default.
- Q92090017 P2093 "Federico Caligaris-Cappio" @default.
- Q92090017 P2093 "Francesca R Mauro" @default.
- Q92090017 P2093 "Johannes Andel" @default.
- Q92090017 P2093 "Kai Riecke" @default.
- Q92090017 P2093 "Lydia Scarfò" @default.
- Q92090017 P2093 "Marco Gobbi" @default.
- Q92090017 P2093 "Marco Montillo" @default.
- Q92090017 P2093 "Matthias Baumann" @default.
- Q92090017 P2093 "Michael Steurer" @default.
- Q92090017 P2093 "Robin Foà" @default.
- Q92090017 P2093 "Sonja Burgstaller" @default.
- Q92090017 P2093 "Sophie Wildner" @default.
- Q92090017 P2093 "Stéphanie Vauléon" @default.
- Q92090017 P2093 "Thomas Dümmler" @default.
- Q92090017 P2860 Q24616084 @default.
- Q92090017 P2860 Q27023060 @default.
- Q92090017 P2860 Q33396737 @default.
- Q92090017 P2860 Q33406164 @default.
- Q92090017 P2860 Q33428297 @default.
- Q92090017 P2860 Q33438825 @default.
- Q92090017 P2860 Q33591830 @default.
- Q92090017 P2860 Q33641404 @default.